Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
BackgroundHelicobacter pylori (H. pylori) is highly prevalent worldwide and is closely associated with many gastric conditions. Current methods for eradicating H. pylori include triple or quadruple therapy, including antibiotics, proton pump inhibitors, and bismuth agents; however, with antibiotic a...
Saved in:
Main Authors: | Manning Li, Ying Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1441185/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Saccharomyces Boulardii and Saccharomyces Cerevisiae Improve Immunity in Broilers Vaccinated Against Pasteurella Multocida and Salmonella Gallinarum
by: C Von Mühlen, et al.
Published: (2025-02-01) -
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01) -
The metabolic profiling of Chinese yam fermented by Saccharomyces boulardii and the biological activities of its ethanol extract in vitro
by: Xue Li, et al.
Published: (2024-09-01) -
Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week
by: A. A. Sheptulin, et al.
Published: (2012-09-01) -
Infection <i>Helicobacter pylori</i> and stomach cancer: state-of-the-art
by: A. A. Sheptulin
Published: (2012-04-01)